- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04303780
Study to Compare AMG 510 "Proposed INN Sotorasib" With Docetaxel in Non Small Cell Lung Cancer (NSCLC) (CodeBreak 200).
A Phase 3 Multicenter, Randomized, Open Label, Active-controlled, Study of AMG 510 Versus Docetaxel for the Treatment of Previously Treated Locally Advanced and Unresectable or Metastatic NSCLC Subjects With Mutated KRAS p.G12C
Study Overview
Status
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Phase 3
Expanded Access
Contacts and Locations
Study Locations
-
-
New South Wales
-
Blacktown, New South Wales, Australia, 2148
- Blacktown Hospital
-
Camperdown, New South Wales, Australia, 2050
- Chris Obrien Lifehouse
-
Kogarah, New South Wales, Australia, 2217
- St George Hospital
-
Liverpool, New South Wales, Australia, 2170
- Liverpool Hospital
-
-
Queensland
-
Chermside, Queensland, Australia, 4032
- Prince Charles Hospital
-
Woolloongabba, Queensland, Australia, 4102
- Princess Alexandra Hospital
-
-
South Australia
-
Woodville South, South Australia, Australia, 5011
- The Queen Elizabeth Hospital
-
-
Victoria
-
Clayton, Victoria, Australia, 3168
- Monash Medical Centre
-
Melbourne, Victoria, Australia, 3000
- Peter MacCallum Cancer Centre
-
-
Western Australia
-
Subiaco, Western Australia, Australia, 6008
- St John of God Healthcare
-
-
-
-
-
Brussels, Belgium, 1000
- Institute Jules Bordet
-
Bruxelles, Belgium, 1200
- Universite Catholique de Louvain Cliniques Universitaires Saint Luc
-
Charleroi, Belgium, 6000
- Grand Hôpital de Charleroi
-
Edegem, Belgium, 2650
- Universitair Ziekenhuis Antwerpen
-
Gent, Belgium, 9000
- Universitair Ziekenhuis Gent
-
Leuven, Belgium, 3000
- Universitair Ziekenhuis Leuven - Campus Gasthuisberg
-
Liege, Belgium, 4000
- Centre Hospitalier Universitaire de Liege
-
Roeselare, Belgium, 8800
- AZ Delta Campus Rumbeke
-
Sint-Niklaas, Belgium, 9100
- Algemeen Ziekenhuis Nikolaas Campus Sint Niklaas
-
-
-
-
-
Rio de Janeiro, Brazil, 22793-080
- Instituto Coi
-
Rio de Janeiro, Brazil, 22250-905
- Centro de Tratamento de Tumores Botafogo
-
São Paulo, Brazil, 01509-900
- Fundacao Antonio Prudente - Hospital A C Camargo
-
-
Rio Grande Do Sul
-
Ijui, Rio Grande Do Sul, Brazil, 98700-000
- Hospital de Caridade de Ijui
-
Porto Alegre, Rio Grande Do Sul, Brazil, 90610-000
- Hospital Sao Lucas da Pontificia Universidade Catolica do Rio Grande do Sul
-
-
São Paulo
-
Sao Paulo, São Paulo, Brazil, 01308-050
- Sociedade Beneficente de Senhoras Hospital Sirio Libanes
-
Sao Paulo, São Paulo, Brazil, 01321-001
- Beneficencia Portuguesa de Sao Paulo
-
Sao Paulo, São Paulo, Brazil, 04501-000
- Oncologia Rede D´Or
-
Sao Paulo, São Paulo, Brazil, 05652-900
- Hospital Israelita Albert Einstein
-
São José Do Rio Preto, São Paulo, Brazil, 15090-000
- Hospital de Base de Sao Jose do Rio Preto
-
-
-
-
Alberta
-
Calgary, Alberta, Canada, T2N 4N2
- Tom Baker Cancer Centre
-
Edmonton, Alberta, Canada, T6G 1Z2
- Cross Cancer Institute
-
-
Ontario
-
Hamilton, Ontario, Canada, L8V 5C2
- Juravinski Cancer Centre
-
London, Ontario, Canada, N6A 5W9
- London Health Sciences Centre
-
Ottawa, Ontario, Canada, K1H 8L6
- The Ottawa Hospital Cancer Centre
-
Toronto, Ontario, Canada, M5G 2M9
- Princess Margaret Cancer Centre
-
-
Quebec
-
Montreal, Quebec, Canada, H2X 3E4
- Centre Hospitalier de L'Universite de Montreal Hopital Notre-Dame
-
-
-
-
-
Herlev, Denmark, 2730
- Herlev og Gentofte Hospital
-
København, Denmark, 2100
- Rigshospitalet
-
Odense C, Denmark, 5000
- Odense Universitetshospital
-
-
-
-
-
Helsinki, Finland, 00290
- Helsingin Yliopistollinen Keskussairaala
-
Helsinki, Finland, 00180
- Docrates Syopasairaala
-
Oulu, Finland, 90220
- Oulu University Hospital
-
Turku, Finland, 20520
- Turku University Hospital
-
-
-
-
-
Brest, France, 29609
- Centre Hospitalier Regional Universitaire - Hopital Morvan
-
Créteil, France, 94010
- Centre Hospitalier Intercommunal de Créteil
-
Grenoble, France, 38700
- Centre Hospitalier Universitaire de Grenoble - Hopital Nord Michallon
-
Lille Cedex, France, 59037
- Centre Hospitalier Universitaire Régional de Lille - Hôpital Albert Calmette
-
Limoges Cedex, France, 87042
- Centre Hospitalier Universitaire de Limoges - Hôpital Dupuytren
-
Lyon, France, 69008
- Centre Leon Berard
-
Marseille Cedex 20, France, 13915
- Centre Hospitalier Universitaire Nord
-
Paris, France, 75014
- Hopital Cochin
-
Paris, France, 75005
- Institut Curie
-
Paris, France, 75018
- Hopital Bichat Claude Bernard
-
Paris Cedex 20, France, 75020
- Hôpital Tenon
-
Pessac Cedex, France, 33604
- Centre Hospitalier Universitaire de Bordeaux - Hopital Haut Leveque
-
Pierre-Benite cedex, France, 69495
- Centre Hospitalier Lyon Sud
-
Rennes, France, 35033
- Centre Hospitalier Universitaire de Rennes - Hopital Pontchaillou
-
Saint Herblain, France, 44800
- Centre Hospitalier de Nantes - Hôpital Nord LaÃ"nnec
-
Strasbourg cedex, France, 67091
- Centre Hospitalier Universitaire de Strasbourg - Nouvel Hopital Civil
-
Toulouse Cedex 9, France, 31059
- Centre Hospitalier Universitaire de Toulouse - Hopital Larrey
-
Villejuif, France, 94805
- Gustave Roussy
-
-
-
-
-
Berlin, Germany, 13125
- Evangelische Lungenklinik
-
Berlin, Germany, 13353
- Charite Universitätsmedizin Berlin, Charité Campus Virchow-Klinikum
-
Dresden, Germany, 01307
- Universitaetsklinikum Carl Gustav Carus
-
Essen, Germany, 45147
- Universitätsklinikum Essen
-
Esslingen am Neckar, Germany, 73730
- Klinikum Esslingen GmbH
-
Frankfurt am Main, Germany, 60590
- Universitätsklinikum Frankfurt/Main
-
Gauting, Germany, 82130
- Asklepios - Fachkliniken München-Gauting
-
Grosshansdorf, Germany, 22927
- LungenClinic Grosshansdorf GmbH
-
Hamburg, Germany, 20251
- Studiengesellschaft Hämato Onkologie Hamburg Prof Laack und Partner
-
Heidelberg, Germany, 69126
- Universitaetsklinikum Heidelberg
-
Immenstadt, Germany, 87509
- Klinikverbund Allgäu
-
Köln, Germany, 50937
- Universitatsklinikum Koln
-
Leipzig, Germany, 04357
- Pneumologisch/onkologisch/internistisches Studienzentrum
-
Moers, Germany, 47441
- Bethanien Krankenhaus
-
Oldenburg, Germany, 26121
- Pius-Hospital Oldenburg
-
-
-
-
-
Athens, Greece, 18547
- Metropolitan Hospital
-
Athens, Greece, 115 22
- Agios Savvas Anticancer Hospital
-
Athens, Greece, 11526
- Henry Dunant Hospital Center
-
Athens, Greece, 11527
- Sotiria General Hospital
-
Athens, Greece, 14564
- General Oncology Hospital of Kifissia Agioi Anargyroi
-
Heraklion - Crete, Greece, 71110
- University Hospital of Heraklion
-
Larissa, Greece, 41110
- University Hospital Of Larissa
-
Patra, Greece, 26504
- University Hospital of Patras
-
Thessaloniki, Greece, 54622
- Bioclinic of Thessaloniki
-
Thessaloniki, Greece, 54007
- Theagenion Cancer Hospital
-
Thessaloniki, Greece, 54645
- EUROMEDICA General Clinic of Thessaloniki
-
Thessaloniki, Greece, 55236
- Agios Loukas Clinic
-
-
-
-
-
Budapest, Hungary, 1083
- Semmelweis Egyetem
-
Budapest, Hungary, 1121
- Orszagos Koranyi Pulmonologiai Intezet
-
Farkasgyepu, Hungary, 8582
- Veszprem Megyei Tudogyogyintezet
-
Gyula, Hungary, 5700
- Bekes Megyei Kozponti Korhaz Pandy Kalman Tagkorhaz
-
Kaposvar, Hungary, 7400
- Somogy Megyei Kaposi Mór Oktató Kórház
-
Miskolc, Hungary, 3529
- Borsod-Abauj-Zemplen Megyei Kozponti Korhaz es Egyetemi Oktatokorhaz
-
Szekesfehervar, Hungary, 8000
- Fejer Megyei Szent Gyorgy Egyetemi Oktato Korhaz
-
Tatabanya, Hungary, 2800
- Szent Borbala Korhaz
-
Torokbalint, Hungary, 2045
- Tudogyogyintezet Torokbalint
-
-
-
-
-
Avellino, Italy, 83100
- Azienda Ospedaliera di Rilievo Nazionale San Giuseppe Moscati
-
Bari, Italy, 70124
- Irccs Istituto Tumori Giovanni Paolo Ii
-
Bologna, Italy, 40138
- Azienda Ospedaliera Universitaria di Bologna Policlinico S Orsola Malpighi
-
Catania, Italy, 95123
- Azienda Ospedaliera Universitaria Policlinico Vittorio Emanuele Presidio Ospedaliero G Rodolico
-
Firenze, Italy, 50134
- Azienda Ospedaliero Universitaria Careggi
-
Milano, Italy, 20133
- Fondazione IRCCS Istituto Nazionale dei Tumori
-
Milano, Italy, 20132
- IRCCS Ospedale San Raffaele
-
Milano, Italy, 20122
- Fondazione IRCCS Ca Granda Ospedale Maggiore Policlinico
-
Monserrato CA, Italy, 09042
- Azienda Ospedaliero Universitaria di Cagliari Policlinico Duilio Casula
-
Monza (MB), Italy, 20900
- Azienda Socio Sanitaria Territoriale di Monza Ospedale San Gerardo
-
Napoli, Italy, 80131
- Azienda Ospedaliera di Rilievo Nazionale Specialistica dei Colli Monaldi
-
Orbassano (TO), Italy, 10043
- Azienda Ospedaliera Universitaria San Luigi Gonzaga
-
Padova, Italy, 35128
- Istituto Oncologico Veneto IRCCS
-
Ravenna, Italy, 48100
- Azienda Unità Sanitaria Locale della Romagna Presidio ospedaliero di Ravenna
-
Roma, Italy, 00168
- Policlinico Universitario Agostino Gemelli
-
Roma, Italy, 00161
- Azienda Ospedaliera Policlinico Umberto I
-
-
-
-
Aichi
-
Nagoya-shi, Aichi, Japan, 466-8560
- Nagoya University Hospital
-
Nagoya-shi, Aichi, Japan, 464-8681
- Aichi Cancer Center Hospital
-
-
Chiba
-
Chiba-shi, Chiba, Japan, 260-8717
- Chiba Cancer Center
-
Kashiwa-shi, Chiba, Japan, 277-8577
- National Cancer Center Hospital East
-
-
Ehime
-
Matsuyama-shi, Ehime, Japan, 791-0280
- National Hospital Organization Shikoku Cancer Center
-
-
Fukuoka
-
Fukuoka-shi, Fukuoka, Japan, 812-8582
- Kyushu University Hospital
-
Fukuoka-shi, Fukuoka, Japan, 811-1395
- National Hospital Organization Kyushu Cancer Center
-
Kitakyushu-shi, Fukuoka, Japan, 807-8556
- Hospital of the University of Occupational and Environmental Health
-
-
Hiroshima
-
Fukuyama-shi, Hiroshima, Japan, 720-0001
- Chugoku Central Hospital of Japan Mutual Aid Association of Public School Teachers
-
Hiroshima-shi, Hiroshima, Japan, 734-8551
- Hiroshima University Hospital
-
-
Hokkaido
-
Sapporo-shi, Hokkaido, Japan, 003-0804
- National Hospital Organization Hokkaido Cancer Center
-
-
Hyogo
-
Akashi-shi, Hyogo, Japan, 673-8558
- Hyogo Cancer Center
-
Himeji-shi, Hyogo, Japan, 670-8520
- National Hospital Organization Himeji Medical Center
-
Itami-shi, Hyogo, Japan, 664-8540
- Itami City Hospital
-
Kobe-shi, Hyogo, Japan, 650-0047
- Kobe City Medical Center General Hospital
-
-
Ishikawa
-
Kanazawa-shi, Ishikawa, Japan, 920-8641
- Kanazawa University Hospital
-
-
Kanagawa
-
Kawasaki-shi, Kanagawa, Japan, 216-8511
- St Marianna University School of Medicine Hospital
-
Sagamihara-shi, Kanagawa, Japan, 252-0375
- Kitasato University Hospital
-
Yokohama-shi, Kanagawa, Japan, 241-8515
- Kanagawa Prefectural Hospital Organization Kanagawa Cancer Center
-
-
Kyoto
-
Kyoto-shi, Kyoto, Japan, 606-8507
- Kyoto University Hospital
-
-
Miyagi
-
Natori-shi, Miyagi, Japan, 981-1293
- Miyagi Cancer Center
-
Sendai-shi, Miyagi, Japan, 980-0873
- Sendai Kousei Hospital
-
-
Niigata
-
Niigata-shi, Niigata, Japan, 951-8566
- Niigata Cancer Center Hospital
-
-
Okayama
-
Okayama-shi, Okayama, Japan, 700-8558
- Okayama University Hospital
-
-
Osaka
-
Habikino-shi, Osaka, Japan, 583-8588
- Osaka Habikino Medical Center
-
Hirakata-shi, Osaka, Japan, 573-1191
- Kansai Medical University Hospital
-
Osaka-shi, Osaka, Japan, 541-8567
- Osaka International Cancer Institute
-
Osaka-shi, Osaka, Japan, 534-0021
- Osaka City General Hospital
-
Osakasayama-shi, Osaka, Japan, 589-8511
- Kindai University Hospital
-
Sakai-shi, Osaka, Japan, 591-8555
- National Hospital Organization Kinki-Chuo Chest Medical Center
-
-
Saga
-
Saga-shi, Saga, Japan, 840-8571
- Saga-Ken Medical Centre Koseikan
-
-
Saitama
-
Kitaadachi-gun, Saitama, Japan, 362-0806
- Saitama Cancer Center
-
-
Shiga
-
Otsu-shi, Shiga, Japan, 520-2192
- Shiga University of Medical Science Hospital
-
-
Tokyo
-
Bunkyo-ku, Tokyo, Japan, 113-8431
- Juntendo University Hospital
-
Chuo-ku, Tokyo, Japan, 104-0045
- National Cancer Center Hospital
-
Koto-ku, Tokyo, Japan, 135-8550
- Cancer Institute Hospital of Japanese Foundation for Cancer Research
-
-
Tottori
-
Yonago-shi, Tottori, Japan, 683-8504
- Tottori University Hospital
-
-
Wakayama
-
Wakayama-shi, Wakayama, Japan, 641-8510
- Wakayama Medical University Hospital
-
-
Yamaguchi
-
Iwakuni-shi, Yamaguchi, Japan, 740-8510
- National Hospital Organization Iwakuni Clinical Center
-
Ube-shi, Yamaguchi, Japan, 755-0241
- National Hospital Organization Yamaguchi Ube Medical Center
-
-
-
-
-
Cheongju-si, Chungcheongbuk-do, Korea, Republic of, 28644
- Chungbuk National University Hospital
-
Goyang-si Gyeonggi-do, Korea, Republic of, 10408
- National Cancer Center
-
Seongnam-si, Gyeonggi-do, Korea, Republic of, 13496
- CHA Bundang Medical Center, CHA University
-
Seongnam-si, Gyeonggi-do, Korea, Republic of, 13620
- Seoul National University Bundang Hospital
-
Seoul, Korea, Republic of, 03080
- Seoul National University Hospital
-
Seoul, Korea, Republic of, 05505
- Asan Medical Center
-
Seoul, Korea, Republic of, 03722
- Severance Hospital Yonsei University Health System
-
Seoul, Korea, Republic of, 06351
- Samsung Medical Center
-
Seoul, Korea, Republic of, 03181
- Kangbuk Samsung Hospital
-
Seoul, Korea, Republic of, 06591
- The Catholic University of Korea Seoul St Marys Hospital
-
Ulsan, Korea, Republic of, 44033
- Ulsan University Hospital
-
-
-
-
-
Amsterdam, Netherlands, 1066 CX
- Nederlands Kanker Instituut Antoni van Leeuwenhoekziekenhuis
-
Groningen, Netherlands, 9713 GZ
- Universitair Medisch Centrum Groningen
-
Nijmegen, Netherlands, 6525 GA
- Radboudumc
-
Rotterdam, Netherlands, 3015 GD
- Erasmus Medisch Centrum
-
Utrecht, Netherlands, 3584 CX
- Universitair Medisch Centrum Utrecht
-
-
-
-
-
Gdansk, Poland, 80-214
- Uniwersyteckie Centrum Kliniczne
-
Lublin, Poland, 20-609
- Instytut Genetyki i Immunologii GENIM Spzoo
-
Poznan, Poland, 60-569
- Szpital Kliniczny Przemienienia Panskiego Uniwersytetu Medycznego im K Marcinkowskiego w Poznaniu
-
Warszawa, Poland, 02-781
- Centrum Onkologii Instytut im Marii Sklodowskiej-Curie
-
Wroclaw, Poland, 53-413
- Dolnoslaskie Centrum Onkologii we Wroclawiu
-
-
-
-
-
Lisboa, Portugal, 1769-001
- Centro Hospitalar Universitario de Lisboa Norte EPE - Hospital Pulido Valente
-
Matosinhos, Portugal, 4464-513
- Unidade Local de Saude de Matosinhos, EPE - Hospital Pedro Hispano
-
Porto, Portugal, 4200-072
- Instituto Portugues de Oncologia do Porto Francisco Gentil, EPE
-
Porto, Portugal, 4099-001
- Centro Hospitalar Universitario do Porto EPE - Hospital de Santo Antonio
-
Porto, Portugal, 4200-319
- Centro Hospitalar Universitario de Sao Joao EPE - Hospital Sao Joao
-
-
-
-
-
Moscow, Russian Federation, 125284
- Clinical hospital 2, Group of companies medsi
-
Nizhniy Novgorod, Russian Federation, 603089
- LLC Tonus
-
Omsk, Russian Federation, 644013
- Omsk Regional Clinical Oncology Dispensary
-
Saint-Petersburg, Russian Federation, 197758
- FSBI Scientific and Research Oncology Institute named after N N Petrov
-
Saint-Petersburg, Russian Federation, 197758
- Saint Petersburg scientifical practical center of specialized kinds of medical care oncological
-
-
-
-
-
Madrid, Spain, 28034
- Hospital Universitario Ramon y Cajal
-
Madrid, Spain, 28041
- Hospital Universitario 12 de Octubre
-
Madrid, Spain, 28046
- Hospital Universitario La Paz
-
-
AndalucÃ-a
-
Malaga, AndalucÃ-a, Spain, 29011
- Hospital Regional Universitario de Malaga
-
-
Canarias
-
Las Palmas de Gran Canaria, Canarias, Spain, 35016
- Hospital Universitario Insular de Gran Canaria
-
-
Cataluña
-
Barcelona, Cataluña, Spain, 08041
- Hospital de La Santa Creu i Sant Pau
-
Barcelona, Cataluña, Spain, 08035
- Hospital Universitari Vall D Hebron
-
Barcelona, Cataluña, Spain, 08036
- Hospital Clinic i Provincial de Barcelona
-
Hospitalet de Llobregat, Cataluña, Spain, 08907
- Instituto Catalan de Oncologia Hospital Duran i Reynals
-
-
Comunidad Valenciana
-
Valencia, Comunidad Valenciana, Spain, 46010
- Hospital Clínico Universitario de Valencia
-
-
Galicia
-
A Coruña, Galicia, Spain, 15006
- Complexo Hospitalario Universitario A Coruña Hospital Teresa Herrera
-
-
Madrid
-
Majadahonda, Madrid, Spain, 28222
- Hospital Universitario Puerta de Hierro Majadahonda
-
-
-
-
-
Gavle, Sweden, 801 87
- Gavle Sjukhus
-
Goteborg, Sweden, 413 45
- Sahlgrenska Universitetssjukhuset
-
Linkoping, Sweden, 581 85
- Universitetssjukhuset i Linköping
-
Lund, Sweden, 221 85
- Skanes universitetssjukhus
-
Stockholm, Sweden, 171 64
- Karolinska Universitetssjukhuset Solna
-
Umea, Sweden, 901 85
- Norrlands Universitetssjukhus
-
-
-
-
-
Basel, Switzerland, 4031
- Universitaetsspital Basel
-
Bern, Switzerland, 3010
- Inselspital Bern
-
Geneve, Switzerland, 1205
- Hopitaux universitaires de Geneve
-
Lausanne, Switzerland, 1011
- Centre Hospitalier Universitaire Vaudois
-
Winterthur, Switzerland, 8401
- Kantonsspital Winterthur
-
Zurich, Switzerland, 8091
- Universitaetsspital Zuerich
-
-
-
-
-
Taichung, Taiwan, 40447
- China Medical University Hospital
-
Taichung, Taiwan, 40705
- Veterans General Hospital - Taichung
-
Tainan, Taiwan, 70403
- National Cheng Kung University Hospital
-
Taipei, Taiwan, 10002
- National Taiwan University Hospital
-
-
-
-
-
Cambridge, United Kingdom, CB2 0QQ
- Addenbrookes Hospital, Cambridge University Hospitals NHS Foundation Trust
-
Edinburgh, United Kingdom, EH4 2XU
- Western General Hospital
-
London, United Kingdom, SW3 6JJ
- Royal Marsden Hospital
-
London, United Kingdom, W1G 6AD
- Sarah Cannon Research Institute UK
-
Manchester, United Kingdom, M20 4BX
- Christie Hospital
-
Nottingham, United Kingdom, NG5 1PB
- Nottingham City Hospital
-
Oxford, United Kingdom, OX3 7LJ
- Churchill Hospital
-
Sutton, United Kingdom, SM2 5PT
- Royal Marsden Hospital
-
-
-
-
California
-
Anaheim, California, United States, 92801
- Pacific Cancer Medical Center Inc
-
Duarte, California, United States, 91010
- City of Hope National Medical Center
-
Long Beach, California, United States, 90813
- Pacific Shores Medical Group Long Beach
-
Los Angeles, California, United States, 90095
- University of California Los Angeles
-
Los Angeles, California, United States, 90095-1772
- University of California Los Angeles
-
Sacramento, California, United States, 95817
- University of California at Davis Medical Center
-
Santa Barbara, California, United States, 93105
- Ridley Tree Cancer Center
-
Stanford, California, United States, 94305
- University of California San Francisco Mission Hall
-
Torrance, California, United States, 90502
- Harbor University of California Los Angeles Medical Center
-
-
Colorado
-
Denver, Colorado, United States, 80218
- Rocky Mountain Cancer Centers
-
-
Connecticut
-
Norwalk, Connecticut, United States, 06856
- Danbury Hospital
-
-
Delaware
-
Newark, Delaware, United States, 19713
- Medical Oncology Hematology Consultants Helen F Graham Cancer Center
-
-
District of Columbia
-
Washington, District of Columbia, United States, 20010
- Washington Cancer Institute at MedStar Washington Hospital
-
-
Florida
-
Fort Myers, Florida, United States, 33901
- Florida Cancer Specialists - Fort Myers
-
Hollywood, Florida, United States, 33021
- Memorial Regional Hospital
-
Saint Petersburg, Florida, United States, 33705
- Florida Cancer Specialists Research North
-
Tallahassee, Florida, United States, 32308
- Florida Cancer Specialists Research Panhandle
-
-
Georgia
-
Atlanta, Georgia, United States, 30332
- Emory University
-
Atlanta, Georgia, United States, 30341
- Northside Hospital, Incorporated
-
-
Illinois
-
North Chicago, Illinois, United States, 60064
- Affiliated Oncologists, LLC
-
-
Indiana
-
Fort Wayne, Indiana, United States, 46804
- Fort Wayne Medical Oncology and Hematology
-
-
Louisiana
-
Shreveport, Louisiana, United States, 71103
- Willis Knighton Cancer Center
-
-
Maryland
-
Clinton, Maryland, United States, 20735
- Maryland Oncology Hematology PA
-
-
Massachusetts
-
Lowell, Massachusetts, United States, 01854
- New York Cancer and Blood Specialists
-
-
Michigan
-
Ann Arbor, Michigan, United States, 48109-1274
- University of Michigan
-
Grand Rapids, Michigan, United States, 49503
- Center for Oncology Clinical Trials
-
-
Minnesota
-
Minneapolis, Minnesota, United States, 55404
- Minnesota Oncology Hematology PA
-
-
Missouri
-
Kansas City, Missouri, United States, 64132
- HCA Midwest Health Kansas City
-
-
Nevada
-
Las Vegas, Nevada, United States, 89169
- Comprehensive Cancer Centers of Nevada
-
-
New Jersey
-
Florham Park, New Jersey, United States, 07932
- Summit Medical Group
-
-
New York
-
Albany, New York, United States, 12208
- New York Oncology Hematology, PC
-
Albany, New York, United States, 12208
- United States Oncology Regulatory Affairs Corporate Office
-
Bronx, New York, United States, 10468
- James J Peters VA Medical Center
-
Bronx, New York, United States, 10461
- Montefiore Einstein Center for Cancer Care
-
Lake Success, New York, United States, 11042
- Northwell Health Monter Cancer Center
-
-
North Carolina
-
Winston-Salem, North Carolina, United States, 27157
- Wake Forest Baptist Health
-
-
Ohio
-
Cincinnati, Ohio, United States, 45219
- Oncology Hematology Care Inc
-
-
Oregon
-
Portland, Oregon, United States, 97227
- Northwest Cancer Specialists - Vancouver
-
-
South Carolina
-
Charleston, South Carolina, United States, 29414
- Charleston Oncology
-
Greenville, South Carolina, United States, 29607
- Saint Francis Hospital, Inc
-
-
Tennessee
-
Chattanooga, Tennessee, United States, 37404
- Tennessee Oncology PLLC
-
Knoxville, Tennessee, United States, 37909
- Tennessee Cancer Specialists
-
Nashville, Tennessee, United States, 37203
- Tennessee Oncology
-
-
Texas
-
Bedford, Texas, United States, 76022
- Texas Oncology-Bedford
-
Dallas, Texas, United States, 75390
- UT Southwestern Medical Center
-
Dallas, Texas, United States, 75246
- Texas Oncology Baylor
-
Fort Worth, Texas, United States, 76104
- The Center for Cancer and Blood Disorders
-
Harlingen, Texas, United States, 78550
- Valley Cancer Associates
-
Houston, Texas, United States, 77030
- University of Texas MD Anderson Cancer Center
-
Irving, Texas, United States, 75063
- US Oncology Research Investigational Products Center
-
Tyler, Texas, United States, 75701
- Hope Cancer Center
-
-
Utah
-
Murray, Utah, United States, 84107
- Intermountain Medical Center
-
-
Virginia
-
Fairfax, Virginia, United States, 22031
- Virginia Cancer Specialists, PC
-
Norfolk, Virginia, United States, 23502
- Virginia Oncology Associates
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Men or women greater than or equal to 18 years old.
- ECOG ≤ 1
- Pathologically documented, previously treated, locally-advanced and unresectable or metastatic NSCLC with KRAS p.G12C mutation confirmed through central testing or have documentation of KRAS p.G12C mutation through Amgen Study 20190294 prior to enrollment
Exclusion Criteria:
- Active brain metastases
- Myocardial infarction within 6 months of study day 1
- Gastrointestinal (GI) tract disease causing the inability to take oral medication
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Docetaxel
|
21 day cycles
|
Experimental: AMG 510
|
21 day cycles
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Progression-free Survival (PFS)
Time Frame: Baseline up to primary analysis data cut-off date (02 August 2022); max time on study as of primary analysis data cut off was 24.3 months
|
PFS was defined as the time from randomization (baseline) until disease progression or death from any cause, whichever occurred first for all participants. Progression was based on blinded independent central review (BICR) of disease response per Response Evaluation Criteria in Solid Tumors version 1.1 (RECIST v1.1). As pre-specified in the statistical analysis plan, for participants who crossed over from docetaxel to AMG 510, the participant's response post first progression or post crossover was not used for the primary analyses. Data are presented per original treatment randomized. |
Baseline up to primary analysis data cut-off date (02 August 2022); max time on study as of primary analysis data cut off was 24.3 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Overall Survival (OS)
Time Frame: Baseline to approximately 6 years
|
Defined as time from randomization to death by any cause
|
Baseline to approximately 6 years
|
Objective Response Rate (ORR)
Time Frame: Baseline to approximately 6 years
|
Defined as complete response (CR ) + partial response (PR)
|
Baseline to approximately 6 years
|
Patient Reported Outcomes (PRO)
Time Frame: Baseline to week 12
|
To be assessed by Patient-reported symptoms from selected PRO-Common Terminology Criteria for Adverse Events questions and GP5 of Functional Assessment of Cancer Therapy Tool General form (FACT-G)
|
Baseline to week 12
|
Quality of Life Assessment
Time Frame: Baseline to week 12
|
To be as assessed by: European Organization for Research and Treatment of Cancer Quality of life Questionnaire Core 13 (EORTC QLQ-LC13) and European Organization for Research and Treatment of Cancer Quality-of-life Questionnaire Core 30 (EORTC QLQ C30)
|
Baseline to week 12
|
Duration of response (DOR)
Time Frame: Baseline to approximately 6 years
|
Defined as time from first evidence of PR or CR to disease progression or death due to any cause, whichever occurs first.
|
Baseline to approximately 6 years
|
Time to response (TTR)
Time Frame: Baseline to approximately 6 years
|
Defined as time from randomization to first evidence of PR or CR
|
Baseline to approximately 6 years
|
Disease control rate (DCR)
Time Frame: Baseline to approximately 6 years
|
Defined as rate of confirmed objective response (CR or PR) + stable disease (SD) per Response Evaluation Criteria in Solid Tumors version (RECIST) v1.1 of at least 6 weeks
|
Baseline to approximately 6 years
|
Number of subjects with Clinically significant changes in vital signs
Time Frame: Approximately 1 year
|
Approximately 1 year
|
|
Number of subjects with treatment-emergent adverse events
Time Frame: Estimated up to approximately 6 years
|
Estimated up to approximately 6 years
|
|
Number of subjects with Clinically significant changes in Laboratory tests
Time Frame: Estimated up to approximately 1 year
|
Estimated up to approximately 1 year
|
|
Number of Subjects with treatment-related adverse events
Time Frame: Estimated up to 6 years
|
Estimated up to 6 years
|
|
Maximum plasma concentration (Cmax)
Time Frame: Estimated up to 4 months
|
To characterize the pharmacokinetics (PK) of AMG 510
|
Estimated up to 4 months
|
Area under the plasma concentration-time curve (AUC)
Time Frame: Estimated up to 4 months
|
To characterize the pharmacokinetics (PK) of AMG 510
|
Estimated up to 4 months
|
Collaborators and Investigators
Sponsor
Investigators
- Study Director: MD, Amgen
Publications and helpful links
Helpful Links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Respiratory Tract Diseases
- Neoplasms
- Lung Diseases
- Neoplasms by Site
- Respiratory Tract Neoplasms
- Thoracic Neoplasms
- Carcinoma, Bronchogenic
- Bronchial Neoplasms
- Lung Neoplasms
- Carcinoma, Non-Small-Cell Lung
- Molecular Mechanisms of Pharmacological Action
- Antineoplastic Agents
- Tubulin Modulators
- Antimitotic Agents
- Mitosis Modulators
- Antineoplastic Agents, Immunological
- Immune Checkpoint Inhibitors
- Docetaxel
- Sotorasib
Other Study ID Numbers
- 20190009
- 2023-508214-42-00 (Other Identifier: CTIS (EU))
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Time Frame
IPD Sharing Access Criteria
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- SAP
- ICF
- CSR
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on KRAS p, G12c Mutated /Advanced Metastatic NSCLC
-
BeBetter Med IncXiangya Hospital of Central South UniversityRecruitingAdvanced or Metastatic Solid Tumor | KRAS G12C MutationChina
-
Lupin Ltd.CompletedA Study of LNP3794 in Subjects With NRAS/KRAS Mutated Advanced or Metastatic Refractory Solid TumorsNRAS/KRAS Mutated Advanced or Metastatic Refractory Solid TumorsUnited Kingdom, Netherlands, Belgium
-
AstraZenecaCompletedLocally Advanced or Metastatic EGFR Mutated NSCLC.Taiwan
-
Revolution Medicines, Inc.RecruitingNon-Small Cell Lung Cancer, NSCLC | KRAS, NRAS, HRAS-mutated NSCLC | KRAS G12C-mutated Solid Tumors, Lung Cancer | Lung Cancer Stage IV, Advanced Solid Tumor, CancerUnited States
-
Suzhou Zelgen Biopharmaceuticals Co.,LtdRecruitingKRAS G12C Mutant Advanced Solid TumorsChina
-
Novartis PharmaceuticalsRecruitingLocally Advanced or Metastatic KRAS G12C-mutated NSCLC With a PD-L1 Expression <1% or a PD-L1 Expression ≥ 1% and an STK11 Co-mutationItaly, Spain, United States, France, Thailand, Malaysia, China, Germany, India, Turkey, Belgium, Argentina, Bulgaria, Netherlands, Hungary, Greece, Portugal, Austria, Singapore, Brazil, United Kingdom
-
Frontier Medicines CorporationRecruitingColorectal Cancer | Pancreatic Cancer | Non Small Cell Lung Cancer | Metastatic Solid Tumor | Solid Tumor, Adult | Unresectable Solid Tumor | KRAS G12C | Advanced Solid Tumors With KRAS G12C MutationsUnited States
-
TheRas, IncRecruitingNSCLC | Metastatic Lung Cancer | Non-small Cell Lung Cancer | Advanced Lung Carcinoma | Metastatic Non-Small Cell Lung Cancer | KRAS G12CUnited States, Australia
-
Jiangsu Aosaikang Pharmaceutical Co., Ltd.CompletedLocally Advanced or Metastatic NSCLCChina
-
Jiangsu Aosaikang Pharmaceutical Co., Ltd.CompletedLocally Advanced or Metastatic NSCLCChina
Clinical Trials on AMG 510
-
Southwest Oncology GroupNational Cancer Institute (NCI)RecruitingLung Adenocarcinoma | Stage IVA Lung Cancer AJCC v8 | Stage IVB Lung Cancer AJCC v8 | Lung Non-Small Cell Carcinoma | Stage IV Lung Cancer AJCC v8 | Recurrent Lung Non-Squamous Non-Small Cell CarcinomaUnited States, Guam
-
AmgenCompletedHealthy SubjectsUnited States
-
AmgenCompletedHealthy ParticipantsUnited States
-
Revolution Medicines, Inc.Sanofi; AmgenActive, not recruitingNon-Small Cell Lung CancerUnited States, Korea, Republic of, Canada, Taiwan, Spain, United Kingdom, Italy, Australia, France, Germany
-
AmgenCompletedHealthy VolunteersUnited States
-
AmgenWithdrawn
-
AmgenCompletedHealthy ParticipantsUnited States
-
AmgenCompletedHealthy ParticipantsUnited States
-
Chong Kun Dang PharmaceuticalCompleted